To start, we point out two medical journal articles that present a few weight-loss drugs gastroparesis side effects reports involving the use of semaglutide (Ozempic, Rybelsus, Wegovy) or dulaglutide (Trulicity):
- Tendency of Semaglutide to Induce Gastroparesis: A Case Report
- Medication-Induced Gastroparesis: A Case Report
Significantly, these medical journal articles provide some helpful information about symptoms and diagnosis of the weight-loss drugs gastroparesis side effects that have been associated with Ozempic, Rybelsus, Wegovy, and Trulicity.
In the past six months on our Drug Injury Watch blog, we have written several times about the weight-loss drugs gastroparesis side effects:
Ozempic / Wegovy: Stomach And Intestinal Problems Can Be Irreversible, Life-threatening — Severe Gastric Side Effects Include Stomach Paralysis, Gastroparesis, And Intestinal Blockages (9/1/23)
Severe Stomach Conditions in Patients Using Semaglutide Weight Loss Drugs From Novo Nordisk — Ozempic, Rybelsus, and Wegovy Use Might Cause Gastroparesis, Gastric Stasis, or Stomach Paralysis (9/13/23)
Ozempic, Wegovy, Other GLP-1 Semaglutide Weight-Loss Drugs Linked to Gastroparesis in Recent Medical Study — Researchers Compared Semaglutide Drugs, Such as Ozempic and Wegovy, to Contrave, a Non-GLP-1 Drug, in Weight-Loss Patients (10/24/23)
We are handling drug injury lawsuits for people who used Ozempic, Rybelsus, Wegovy, or Trulicity and then were diagnosed with the weight-loss drugs gastroparesis side effects.
[Read article in full at original source]Ozempic / Rybelsus / Wegovy/ Trulicity
Free Case Evaluation
Strictly Confidential, No Obligation